Article
Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
The Journal of clinical endocrinology and metabolism - 1 Dec 2008
Rus Ramona, Haag Christine, Bumke-Vogt Christiane, Bähr Volker, Mayr Bernhard, Möhlig Matthias, Schulze Egbert, Frank-Raue Karin, Raue Friedhelm, Schöfl Christof
Abstract excerpt
CONTEXT AND OBJECTIVE: Inactivating mutations in the calcium-sensing receptor (CaSR) gene cause neonatal severe hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH). The aims of the present study were the functional characterization of novel mutations of the CaSR found in FHH patients, the comparison of in vitro receptor function with clinical parameters, and the effect of the allosteric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
